← Eichor
Study identifier: NCT07114393 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of Intracoronary Imaging Versus Contemporary Practice

Condition: Coronary Artery Disease · Coronary Artery Disease (Left Main) · Chronic Total Occlusion (CTO)  ·  Sponsor: Cathreine BV

PhaseN/A
Planned participants11092
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Coronary artery disease remains a leading cause of mortality worldwide and is commonly treated with percutaneous coronary intervention (PCI). Typically, PCI is guided by invasive coronary angiography (ICA). However, ICA has inherent limitations in accurately assessing vessel dimensions, calcium burden, circumferential tissue and whether a stent has achieved full expansion. Therefore ICA alone is insufficient for guiding stent optimization, especially in complex lesions which are most vulnerable to long-term stent failure. To overcome the limitations of ICA, intracoronary imaging can be used to guide and optimize PCI. The advantages of intracoronary imaging include obtaining larger lumen areas, better stent expansion and strut apposition, full lesion stent coverage and identifying stent complications. Multiple randomized studies have shown that these advantages translate into a reduction in major adverse cardiovascular events (MACE) in complex PCI. Consequently, the recommendation for intracoronary imaging has been upgraded in the most recent guidelines. Despite robust evidence supporting its benefits, intracoronary imaging remains relatively underused in real-world practice and in the Netherlands it is only used in 7% of complex PCI procedures. This underutilization may be attributed to several factors, including operator and hospital-dependent issues such as lack of experience, reluctance to spend additional time on intracoronary imaging and concerns about its cost-effectiv…

This description comes directly from the study's public registry record.

Talk to the study team

Koen Teeuwen, MD PhD  ·  + 31 040 239 9111  ·  koen.teeuwen@catharinaziekenhuis.nl

Konrad AJ van Beek, MD  ·  + 31 040 239 9111  ·  konrad.v.beek@catharinaziekenhuis.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Catharina hospital EindhovenEindhoven, North Brabant, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07114393